The Effect of a Smartphone-assisted Hybrid Cardiac Rehabilitation Program in Patients With Heart Failure.
SHCR-HF
1 other identifier
interventional
150
1 country
1
Brief Summary
The aim of this randomized controlled trial is to compare the impact of a case manager-led smartphone-assisted hybrid cardiac rehabilitation program with usual care in patients with HF. Participants will undergo a 12-week program led by a case manager and assisted by a smartphone. The study aims to answer two main questions:
- 1.Is the novel cardiac rehabilitation model feasible for patients with HF?
- 2.Does the intervention group show a significant improvement in exercise capacity and adherence compared to the usual care group?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable heart-failure
Started Jan 2024
Longer than P75 for not_applicable heart-failure
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 1, 2023
CompletedFirst Posted
Study publicly available on registry
May 24, 2023
CompletedStudy Start
First participant enrolled
January 26, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2028
September 29, 2025
September 1, 2025
4.9 years
May 1, 2023
September 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change of peak oxygen uptake
Peak oxygen uptake will be assessed using cardiopulmonary exercise test before intervention, at 12 weeks (post-intervention), and at 6 months.
at baseline, 12 weeks(post-intervention), and 6 months.
Change of 6 minute walking test
6 minute walking test will be performed before intervention, at 12 weeks (post-intervention), and at 6 months.
at baseline, 12 weeks(post-intervention), and 6 months.
Secondary Outcomes (12)
Adherence to prescribed exercise
12 weeks(post-intervention)
Evaluation of Quality of life
at baseline, 12 weeks(post-intervention), and 6 months.
Depression
at baseline, 12 weeks(post-intervention), and 6 months.
Anxiety
at baseline, 12 weeks(post-intervention), and 6 months.
Evaluation of physical activity
at baseline, 12 weeks(post-intervention), and 6 months.
- +7 more secondary outcomes
Study Arms (2)
smartphone-assisted hybrid cardiac rehabilitation (SHCR)
EXPERIMENTALParticipants receive a 12-wk case manager-led smartphone-assisted hybrid cardiac rehabilitation with follow-up at 12 week and 6 months.
Usual care
NO INTERVENTIONParticipants receive usual care including general education and exercise suggestion.
Interventions
The 12-week case manager-led SHCR program includes: * Customized exercise prescriptions following ACSM's heart failure guidelines. * A hybrid program combining in-person sessions, home self-exercise, and videoconferencing for exercise coaching(optional), supported by a smartphone app. * Case managers instruct patients on a communication app for weekly follow-ups, health education messages, exercise reminders, and progress tracking, including metrics like blood pressure, heart rate, weight, and symptoms.
Eligibility Criteria
You may qualify if:
- Patients with heart failure between the ages of 18 and 80 years old.
- NYHA (New York Heart Association) functional classification of 1 to 3.
- Patients must be in a stable condition and under outpatient follow-up.
You may not qualify if:
- Patients who have contraindications for exercise according to the American College of Sports Medicine's Guidelines for Exercise Testing and Prescription.
- Patients who are unable to complete cardiopulmonary exercise testing.
- Patients who are unable to follow verbal instructions.
- Patients who are unable to walk independently or pedal a stationary bicycle.
- Patients who are unable to use communication app on a smartphone.
- Patients who already engage in physical activity exceeding the recommended moderate intensity of 150 minutes per week or are currently participating in cardiac rehabilitation.
- Patients who do not provide consent to participate in the trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Physical Medicine and Rehabilitation, National Taiwan University Hospital
Taipei, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hung-Jui Chuang, MD
Department of Physical Medicine and Rehabilitation, National Taiwan University Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 1, 2023
First Posted
May 24, 2023
Study Start
January 26, 2024
Primary Completion (Estimated)
December 1, 2028
Study Completion (Estimated)
December 1, 2028
Last Updated
September 29, 2025
Record last verified: 2025-09